About AIonios
AIonios is at the forefront of AI-driven antibody engineering, revolutionizing the field with cutting-edge technology and innovative approaches.
About Us
Pioneering AI in Antibody Engineering
At AIonios, we're dedicated to revolutionizing the field of antibody engineering through the power of artificial intelligence.
Our Mission
We believe that by combining the expertise of seasoned biologists with state-of-the-art AI technologies, we can unlock new possibilities in antibody design and optimization, leading to more effective and safer treatments for patients worldwide.
Accelerate drug discovery
Improve antibody efficacy
Reduce development costs
Enhance patient outcomes
Foster scientific collaboration
Push the boundaries of AI in biotech
Meet Our Team
Our diverse team of experts is dedicated to pushing the boundaries of what's possible in antibody engineering.
Nikolaos Koutavas
Co-Founder
Michael P. Manis
Co-Founder